Michael Mangano
Chief Executive Officer chez ABK Biomedical, Inc.
Profil
Michael J.
Mangano is currently the President, Chief Executive Officer & Director at ABK Biomedical, Inc. He previously held positions as the President, Chief Executive Officer & Director at ReShape Medical, Inc., Independent Director at Nova Eye Medical Ltd.
from 2018 to 2020, and Head-US Region at Sirtex Medical Pty Ltd.
from 2010 to 2013.
Postes actifs de Michael Mangano
| Sociétés | Poste | Début |
|---|---|---|
ABK Biomedical, Inc.
 ABK Biomedical, Inc. BiotechnologyHealth Technology ABK Biomedical, Inc. develops embolotherapeutic products for the treatment of uterine fibroids. It engages in the development, production and sale of embolic agents and peripheral vascular delivery devices. The company was founded by Bob Abraham, Daniel Boyd and Sharon Kehoe in 2012 and is headquartered in Halifax, Canada. | Chief Executive Officer | 30/07/2018 |
Anciens postes connus de Michael Mangano
| Sociétés | Poste | Fin |
|---|---|---|
| NOVA EYE MEDICAL LIMITED | Director/Board Member | 31/08/2020 |
ReShape Medical, Inc.
 ReShape Medical, Inc. Medical SpecialtiesHealth Technology ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA. | Chief Executive Officer | - |
| SIRTEX MEDICAL LIMITED | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVA EYE MEDICAL LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
ReShape Medical, Inc.
ReShape Medical, Inc. Medical SpecialtiesHealth Technology ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA. | Health Technology |
Sirtex Medical Pty Ltd.
 Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Sirtex Medical Ltd. manufactures, and distributes liver cancer treatments. It operates through the following geographical segments: Asia Pacific, Americas, and Europe, Middle East, and Africa. It offers targeted radiation therapy known as SIR Spheres Y-90 resin microspheres. The company was founded in 1997 and is headquartered in St Leonards, Australia. | Commercial Services |
ABK Biomedical, Inc.
ABK Biomedical, Inc. BiotechnologyHealth Technology ABK Biomedical, Inc. develops embolotherapeutic products for the treatment of uterine fibroids. It engages in the development, production and sale of embolic agents and peripheral vascular delivery devices. The company was founded by Bob Abraham, Daniel Boyd and Sharon Kehoe in 2012 and is headquartered in Halifax, Canada. | Health Technology |
